{
    "nct_id": "NCT05417100",
    "official_title": "Modulation of Post-operative Opioid Consumption and Pain by Intraoperative Methadone for Cancer Related Spinal Surgery - An Investigator Initiated Trial (IIT), Cluster Randomization Trial",
    "inclusion_criteria": "* Adult patients (between 18-75 years of age) scheduled for extradural spine surgery with instrumentation (greater than or equal to two levels and including minimally invasive) of expected duration ≥ 2 hours\n* Postoperative hospital stay expected to be ≥ 2 nights at the time of consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
    "exclusion_criteria": "* Use of methadone currently or within the previous 6 weeks\n* Drug misuse history (e.g., ketamine, cocaine, heroin, amphetamine, methamphetamine, MDMA, phencyclidine, lysergic acid, mescaline, psilocybin).\n* Current use of opioid antagonist/partial antagonist (i.e. buprenorphine).\n* Current or past diagnosis of a Major Psychiatric disorder (such as Schizophrenia, dementia, delirium).\n* Patients with a BMI ≥ 36 kg/m2\n* 2nd or 3rd degree heart block as assessed by preoperative EKG.\n* QTc > 450 msec on preoperative EKG.\n* Documentation of congestive heart failure and/or ejection fraction < 30% if recorded in the Pre-Operative Record.\n* Contraindication to use of any analgesic medications listed in the ERAS pathways (acetaminophen, gabapentin, celecoxib, IV opioids).\n* Any known hypersensitivity to methadone.\n* Pregnant or breastfeeding.\n* Abnormal liver function tests as related to the MSK guidelines for use of IV acetaminophen: ALT greater than 2 x Upper Limit of Normal (> 75 U/L)\n* Serum Creatinine > 1.5 mg/dl\n* Instrumented spine cases of less than 2 levels\n* All non-instrumented spine cases\n* All intradural tumor resections\n* All \"take backs\" that occur within 72 hours of surgery (wound revisions, hematomas, etc.)",
    "miscellaneous_criteria": ""
}